Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225860 · ClinicalTrials.gov registry record · Phase 2
Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
A Phase 2 study, sponsored by Tufts Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
NCT02225860 is a Phase 2 study that has completed, run by Tufts Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT02225860, a Phase 2 study, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if dietary habits can affect vasopressin secretion in patients with autosomal dominant polycystic kidney disease. Vasopressin increases the growth of kidney cysts and accelerates disease progression. Understanding how to control secretion of this hormone based on dietary habits may help to develop treatments to control this disease. The study will include about 60 patients from Tufts Medical Center. The study will last for 2 weeks. Blood and urine tests will be done 3 times during the study period. Subjects will be randomly assigned (by chance like flipping a coin), to one of two study groups. Group 1 will be given instructions to adjust their diet. This will include adjusting the amount of water, protein, and salt intake. Group 2 will have no adjustment of diet or water. The project has tremendous public health relevance, given the large numbers of people affected by autosomal dominant polycystic kidney disease and the substantial impact of the disease on morbidity, mortality, hospitalizations,dialysis or transplant, and societal costs of caring for those patients.
Interventions
- BEHAVIORAL Diet and water adjustment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02225860
The ClinicalTrials.gov registry entry for NCT02225860 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diet and water adjustment is the first listed.
NCT02225860 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02225860 about?
NCT02225860 is a clinical study titled "Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease". The purpose of this study is to learn if dietary habits can affect vasopressin secretion in patients with autosomal dominant polycystic kidney disease. Vasopressin increases the growth of kidney cysts and accelerates disease progression. Understanding how to control secretion of this hormone based o...
What is the current status of trial NCT02225860?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2014-05. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02225860?
The interventions under investigation include: Diet and water adjustment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02225860?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.